Drug targeting using thermally responsive polymers and local hyperthermia.

We report a new thermal targeting method in which a thermally responsive drug carrier selectively accumulates in a solid tumor that is maintained above physiological temperature by externally applied, focused hyperthermia. We synthesized two thermally responsive polymers that were designed to exhibit a lower critical solution temperature (LCST) transition slightly above physiological temperature: (1) a genetically engineered elastin-like polypeptide (ELP) and (2) a copolymer of N-isopropylacrylamide (NIPAAm) and acrylamide (AAm). The delivery of systemically injected polymer-rhodamine conjugates to solid tumors was investigated by in vivo fluorescence video microscopy of ovarian tumors implanted in dorsal skin fold window chambers in nude mice, with and without local hyperthermia. When tumors were heated to 42 degrees C, the accumulation of a thermally responsive ELP with a LCST of 40 degrees C was approximately twofold greater than the concentration of the same polymer in tumors that were not heated. Similar results were also obtained for a thermally responsive poly(NIPAAM-co-AAm), though the enhanced accumulation of this carrier in heated tumors was lower than that observed for the thermally responsive ELP. These results suggest that enhanced delivery of drugs to solid tumors can be achieved by conjugation to thermally responsive polymers combined with local heating of tumors.

[1]  G. Rosner,et al.  Measurement of material extravasation in microvascular networks using fluorescence video-microscopy. , 1993, Microvascular research.

[2]  R. Panchagnula,et al.  Monoclonal antibodies in drug targeting , 1997, Journal of clinical pharmacy and therapeutics.

[3]  E. Ruoslahti,et al.  Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. , 1998, Science.

[4]  Howard G. Schild,et al.  Cononsolvency in mixed aqueous solutions of poly(N-isopropylacrylamide) , 1991 .

[5]  B Mattiasson,et al.  'Smart' polymers and what they could do in biotechnology and medicine. , 1999, Trends in biotechnology.

[6]  T. M. Parker,et al.  Temperature of polypeptide inverse temperature transition depends on mean residue hydrophobicity , 1991 .

[7]  T. Samulski,et al.  Heating deep seated eccentrically located tumors with an annular phased array system: a comparative clinical study using two annular array operating configurations. , 1987, International journal of radiation oncology, biology, physics.

[8]  J. Murgo,et al.  Microsphere and dilution techniques for the determination of blood flows and volumes in conscious mice. , 1992, The American journal of physiology.

[9]  R K Jain,et al.  Barriers to drug delivery in solid tumors. , 1994, Scientific American.

[10]  P. Durbin,et al.  Gross composition and plasma and extracellular water volumes of tissues of a reference mouse. , 1992, Health physics.

[11]  John W. Strohbehn,et al.  Experience with a Multitransducer Ultrasound System for Localized Hyperthermia of Deep Tissues , 1984, IEEE Transactions on Biomedical Engineering.

[12]  R. Roemer,et al.  Oscillatory temperature response to constant power applied to canine muscle. , 1985, The American journal of physiology.

[13]  Charles K. Chiklis,et al.  Swelling of thin films. I. Acrylamide–N‐isopropylacrylamide copolymers in water , 1970 .

[14]  S. Yuk,et al.  Phase-transition polymers for drug delivery. , 1999, Critical reviews in therapeutic drug carrier systems.

[15]  M. Dewhirst,et al.  Hyperthermia and liposomes. , 1999, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[16]  H. Fujita.  [Anticancer drugs]. , 1995, Nihon rinsho. Japanese journal of clinical medicine.

[17]  J. Taillefer,et al.  Preparation and characterization of pH-responsive polymeric micelles for the delivery of photosensitizing anticancer drugs. , 2000, Journal of pharmaceutical sciences.

[18]  Jindrich Kopecek,et al.  Polymerizable Fab′ antibody fragments for targeting of anticancer drugs , 1999, Nature Biotechnology.

[19]  Jan Feijen,et al.  Effect of comonomer hydrophilicity and ionization on the lower critical solution temperature of N-isopropylacrylamide copolymers , 1993 .

[20]  Robert B. Roemer,et al.  A uniform thermal field in a hyperthermia chamber for microvascular studies , 1982 .

[21]  T. Okano,et al.  Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate). , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[22]  F. Waterman,et al.  Thermoradiotherapy in the management of superficial malignant tumors. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  Purification of recombinant proteins , 1996 .

[24]  Howard G. Schild,et al.  Microcalorimetric detection of lower critical solution temperatures in aqueous polymer solutions , 1990 .

[25]  Jie Xu,et al.  Product purification by reversible phase transition following Escherichia coli expression of genes encoding up to 251 repeats of the elastomeric pentapeptide GVGVP. , 1996, Protein expression and purification.

[26]  A. Hoffman,et al.  Lower critical solution temperatures of aqueous copolymers of N-isopropylacrylamide and other N-substituted acrylamides , 1987 .

[27]  Ick Chan Kwon,et al.  Saccharide effect on the lower critical solution temperature of thermosensitive polymers , 1995 .

[28]  H. G. Schild.  Poly(N-isopropylacrylamide): experiment, theory and application , 1992 .

[29]  R. Freitag,et al.  Investigation of the LCST of polyacrylamides as a function of molecular parameters and the solvent composition , 1999 .

[30]  T. Feyerabend,et al.  Rationale and clinical status of local hyperthermia, radiation, and chemotherapy in locally advanced malignancies. , 1997, Anticancer research.

[31]  S. Badylak,et al.  Hyperthermia‐induced vascular injury in normal and neoplastic tissue , 1985, Cancer.

[32]  Oscar Chiantore,et al.  Solution properties of poly(N‐isopropylacrylamide) , 1979 .

[33]  Ashutosh Chilkoti,et al.  Purification of recombinant proteins by fusion with thermally-responsive polypeptides , 1999, Nature Biotechnology.

[34]  S. B. Field,et al.  An Introduction to the Practical Aspects of Clinical Hyperthermia , 1990 .

[35]  P. F. Turner,et al.  Mini-Annular Phased Array for Limb Hyperthermia , 1986 .

[36]  J. Rhee,et al.  Implication of Blood Flow in Hyperthermic Treatment of Tumors , 1984, IEEE Transactions on Biomedical Engineering.

[37]  M. Gaze.  The current status of targeted radiotherapy in clinical practice. , 1996, Physics in medicine and biology.

[38]  P. Vaupel,et al.  Physiological effects of hyperthermia. , 1987, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[39]  R. Duncan,et al.  Drug-polymer conjugates: potential for improved chemotherapy. , 1992, Anti-cancer drugs.

[40]  M. Jones,et al.  Polymeric micelles - a new generation of colloidal drug carriers. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[41]  D. Urry,et al.  Phase‐structure transitions of the elastin polypentapeptide–water system within the framework of composition–temperature studies , 1985, Biopolymers.

[42]  V. Torchilin.  Polymer-coated long-circulating microparticulate pharmaceuticals. , 1998, Journal of microencapsulation.

[43]  D. Urry.  Physical Chemistry of Biological Free Energy Transduction As Demonstrated by Elastic Protein-Based Polymers† , 1997 .

[44]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[45]  M. Dewhirst,et al.  Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia. , 2001, Cancer research.

[46]  M. Dewhirst,et al.  Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. , 1996, International journal of radiation oncology, biology, physics.

[47]  D. Urry.  Free energy transduction in polypeptides and proteins based on inverse temperature transitions. , 1992, Progress in biophysics and molecular biology.

[48]  F Liu,et al.  Modulating insulin-release profile from pH/thermosensitive polymeric beads through polymer molecular weight. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[49]  Nikolaos A. Peppas,et al.  Pulsatile local delivery of thrombolytic and antithrombotic agents using poly(N-isopropylacrylamide-co-methacrylic acid) hydrogels , 1996 .

[50]  T. Okano,et al.  Pulsatile drug delivery systems using hydrogels , 1993 .

[51]  E. Hersh,et al.  Phase I trial of recombinant interleukin 3 before and after carboplatin/etoposide chemotherapy in patients with solid tumors: a southwest oncology group study. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[52]  D Needham,et al.  Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue. , 1993, Cancer research.

[53]  J F Gross,et al.  Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. , 1989, International journal of radiation oncology, biology, physics.

[54]  Mark W. Dewhirst,et al.  Review Hyperthermia and liposomes , 1999 .

[55]  R. Langer,et al.  Drug delivery and targeting. , 1998, Nature.

[56]  M. Dewhirst.  Future directions in hyperthermia biology. , 1994, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[57]  G. Rosner,et al.  Hyperthermic treatment of malignant diseases: current status and a view toward the future. , 1997, Seminars in oncology.

[58]  Allan S. Hoffman,et al.  “intelligent” polymers in medicine and biotechnology , 1995 .

[59]  K. Engin.  Biological rationale and clinical experience with hyperthermia. , 1996, Controlled clinical trials.

[60]  K Hynynen,et al.  Ultrasound technology for hyperthermia. , 1999, Ultrasound in medicine & biology.

[61]  R. Issels.  Hyperthermia Combined with Chemotherapy – Biological Rationale, Clinical Application, and Treatment Results , 1999, Oncology Research and Treatment.

[62]  L. D. Taylor,et al.  Preparation of films exhibiting a balanced temperature dependence to permeation by aqueous solutions—a study of lower consolute behavior , 1975 .

[63]  Chuan Yi Tang,et al.  A 2.|E|-Bit Distributed Algorithm for the Directed Euler Trail Problem , 1993, Inf. Process. Lett..